- Record: found
- Abstract: not found
- Article: not found
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
S Alpert, G Gregoratos, E M Antman, Carl J. Pepine, , Shannon Hiratzka, Eugene Braunwald, Laura N. Levin, Stephen W Schaeffer, Laura-Jane Smith, Spencer Beasley, Joel Kupersmith, M Cheitlin, David Faxon, Theodore R. Gibbons, Ashley K. Jacobs, David E Steward, Gordon C. S. Smith, Valentin Fuster, Robert Califf, Alison Jones, Paula Hochman, Dean Kereiakes, Pierre Théroux
2002-10-01
Angina, Unstable, blood, complications, therapy, Angioplasty, Balloon, Coronary, Antibodies, Monoclonal, adverse effects, therapeutic use, Anticoagulants, Biological Markers, Disease Management, Drug Therapy, Combination, Electrocardiography, Female, Health Behavior, Hemorrhage, etiology, Humans, Hypolipidemic Agents, Immunoglobulin Fab Fragments, Male, Myocardial Infarction, Peptides, Platelet Aggregation Inhibitors, Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors, Randomized Controlled Trials as Topic, statistics & numerical data, Risk Assessment, Risk Factors, Ticlopidine, analogs & derivatives, Tyrosine
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Angina, Unstable,blood,complications,therapy,Angioplasty, Balloon, Coronary,Antibodies, Monoclonal,adverse effects,therapeutic use,Anticoagulants,Biological Markers,Disease Management,Drug Therapy, Combination,Electrocardiography,Female,Health Behavior,Hemorrhage,etiology,Humans,Hypolipidemic Agents,Immunoglobulin Fab Fragments,Male,Myocardial Infarction,Peptides,Platelet Aggregation Inhibitors,Platelet Glycoprotein GPIIb-IIIa Complex,antagonists & inhibitors,Randomized Controlled Trials as Topic,statistics & numerical data,Risk Assessment,Risk Factors,Ticlopidine,analogs & derivatives,Tyrosine
Angina, Unstable, blood, complications, therapy, Angioplasty, Balloon, Coronary, Antibodies, Monoclonal, adverse effects, therapeutic use, Anticoagulants, Biological Markers, Disease Management, Drug Therapy, Combination, Electrocardiography, Female, Health Behavior, Hemorrhage, etiology, Humans, Hypolipidemic Agents, Immunoglobulin Fab Fragments, Male, Myocardial Infarction, Peptides, Platelet Aggregation Inhibitors, Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors, Randomized Controlled Trials as Topic, statistics & numerical data, Risk Assessment, Risk Factors, Ticlopidine, analogs & derivatives, Tyrosine